FDA Proposes Changes to Informed Consent Rules

Nov 14, 2018, 10:28 by Michael Croft

RAPS | On Tuesday, FDA proposed changes that would allow Institutional Review Boards to waive or alter requirements for obtaining informed consent for certain clinical trials involving minimal risk to participants.

November 14, 2018 | On Tuesday, FDA proposed changes that would allow Institutional Review Boards to waive or alter requirements for obtaining informed consent for certain clinical trials involving minimal risk to participants. RAPS